Inside EU Health Inside EU Health: Illicit drugs report; tobacco and nicotine; Ebola latest EU Drugs Agency warns of new health risks, including a rising trend in ketamine use; Smoke Free Partnership accuses tobacco lobby of ‘dirty tricks’ in EU consultation; EU commits further €16.5 million for Ebola outbreak
Inside EU Health Inside EU Health: Nicotine taxation; Wegovy; Várhelyi defends EU’s approach; future-proof vaccine Sweden blocks tobacco tax package; Wegovy pill prescribed once every five seconds; Von der Leyen wants faster development of new cancer treatments; Várhelyi says unilateral measures by the US against the EU ‘would not be justified’; a future-proofed vaccine could prevent pandemics before they begin
Inside EU Health Inside EU Health: Biotech Act; EU budget; patient organisations ENVI committee raises doubts over Biotech Act SPC extension; 490 health experts urge EU to ring-rence €10 billion for health in EU budget; barometer on the involvement of patient organisations
Inside EU Health Inside EU Health: ECDC; workforce; Ebola update; European semester ECDC chief warns MEPs more health threats require more resources; health sector hails EU vote on workforce crisis as ‘major step forward’ WHO has only 35% of the funds it needs for its Ebola response; European semester recommendations target stronger and more resilient health systems
Inside EU Health Inside EU Health: Swedes hold key to tobacco taxation; economic cost of menopause; Finnish first in AI and health Sweden could be the last obstacle to a tobacco and nicotine tax agreement; menopause costs the EU economy €17.3 billion a year; Finland backs a world-first nationwide AI model to boost decision-making in healthcare
Inside EU Health Inside EU Health: Nicotine and tobacco; Ebola update; EHDS From tobacco-free to tobacco and nicotine-free generation; CEPI backs three possible Bundibugyo ebolavirus vaccine candidates; Patients call for stronger role in shaping Europe’s Health Data Space
Inside EU Health Inside EU Health: Anti-dumping; Ebola; hantavirus; EMA recommendations Sandoz says situation has reached ‘breaking point’; WHO risk assessment raises DRC to ‘very high’; further hantavirus positive test in Spain; EMA recommends eight new medicines for approval
Inside EU Health Inside EU Health: Sexually transmitted diseases; safety at work; hantavirus Sexually transmitted diseases are rising sharply; Parliament pushes a ‘Vision Zero’ for workplace accidents; MEPs clash over EU health powers after MV Hondius hantavirus outbreak
Inside EU Health Inside EU Health: Tobacco control; EU/US trade deal; clinical trials; CEPI; scaleup fund Europe is backslking on tobacco control; EU-US ‘Turnberry’ trade deal back on track; EU first report charting progress on its clinical trials ambitions; EU commits €73.7 million CEPI 100-day mission; EQT selected to manage EU Scaleup Europe Fund
Inside EU Health Inside EU Health: WAITing; Ebola; tobacco consultation; UK/US pharma deal WAITing for medicines; WHO releases further $3.4 million for Ebola outbreak; Commission launches consultation on tobacco regulation; NGOs challenge UK-US medicines pricing deal
Inside EU Health Inside EU Health: Ebola update; nicotine pouches; biosecurity; WHA; hantavirus Ebola declared emergency of international concern; WHO warns nicotine pouches risk hooking a new generation; EuropaBio ups efforts on biosecurity; World Health Assembly kicks off; EU activates crisis response mechanism to monitor hantavirus outbreak
Inside EU Health Inside EU Health: Global Health Resilience Initiative; critical medicines act; social media restrictions ‘Global Health Resilience Initiative’ disappoints; EU seals deal on Critical Medicines Act after marathon talks; EU could propose social media age restrictions as early as the summer
Inside EU Health Inside EU Health: Critical Medicines Act; Hantavirus ship; Várhelyi cleared Cypriots compromise to seal critical medicines deal; Hantavirus ship disembarks in Tenerife; Várhelyi cleared in Commission spying investigation
Inside EU Health Inside EU Health: Critical Medicines Act; Urban Wastewater Treatment; novel nicotine; hantavirus update Várhelyi says critical medicines deal possible as early as next week; Várhelyi ‘partner for any solution’ on Urban Wastewater Treatment Directive; novel nicotine products will be treated like cigarettes; latest WHO briefing on hantavirus
Inside EU Health Inside EU Health: First EU joint clinical assessment; Hantavirus; protecting healthcare in conflict zones; disability First EU joint clinical assessment is a milestone; Hantavirus poses little risk to wider public; international organisations mark failure to protect health care in conflict zones; disabled people face disproportionate discrimination in public services
Inside EU Health Inside EU Health: Pandemic agreement delayed; OECD puts a price on poor mental health; Epi+ preparedness; mpox ‘Last piece of the puzzle’ in the WHO pandemic agreement delayed to 2027; OECD puts €76 billion price tag on the poor mental health in the EU; Epi+ live will go live in June 2027; ECDC launch monthly mpox surveillance report
Inside EU Health Inside EU Health: EMA vaccine confidence group; limits on vapes; liver health crisis EMA steps up vaccine misinformation fight; Europe’s liver health crisis demands urgent action
Inside EU Health Inside EU Health: EMA pilot for 'breakthrough' medical devices; snus; future budget EMA pilot to fast-track breakthrough medical devices; Snus’s generational impact on asthma and allergies; MEPs adopt position on EU’s long-term budget reinforcing health measures
Inside EU Health Inside EU Health: Medicines for Europe appeals court decision; pharmaceutical exports support 926,000 EU jobs Generic makers appeal to fix tax on treatment; pharmaceutical exports supported 926 000 EU jobs
Inside EU Health Inside EU Health: UK Biobank suspended; France chooses ‘sovereign’ cloud for health data; latest EMA medicines approvals UK Biobank suspends access following Alibaba revelations; France chooses ‘sovereign’ cloud for health data; EMA recommends five new medicines, including a first-in-class small interfering RNA treatment
Inside EU Health Inside EU Health: UK Tobacco and Vapes Bill; GLP-1 pill for type-2 diabetes in adolescents; maternity and paternity leave across the EU UK Tobacco and Vapes Bill clears final hurdle; Novo Nordisk announces positive results for GLP-1s for teenagers with type 2 diabetes; Maternity and paternity leave across the EU-27
Inside EU Health Inside EU Health: AZ warns Germany; fair pricing savings €27 B; safe heart screening AstraZeneca warns German reforms could push pharma launches and investment out of Europe; fair pricing model highlights €27 billion of potential savings in Europe; Commission launches consultation on screening for cardiovascular diseases
Inside EU Health Inside EU Health: Support for health NGOs; Europe’s East-West healthcare divide; Hungarian health minister European Patients’ Forum welcomes MEP support to restore funding for health NGO’s; Europe’s East-West healthcare divide; From viral victory dance to cabinet role, Hegedűs named as new Hungarian health minister
Inside EU Health Inside EU Health: HPV vaccination; ageing population; UK Covid report on vaccines and therapeutics ECDC underscores advances in HPV vaccination for European Immunisation Week; Europe’s demographic challenge will likely hit healthcare; UK COVID-19 Report: Vaccines and therapeutics
Inside EU Health Inside EU Health: EU4Health; Age-verification app; patient-centre health Parliament budget committee backs €10bn EU4Health fund; EU offers COVID-style app for age verification; Várhelyi has a follow-up roundtable with the health sector; what is patient-centred health research?
